Gut Microbes,
Journal Year:
2023,
Volume and Issue:
15(2)
Published: Nov. 7, 2023
The
advent
of
highthroughput
‘omics’
technologies
has
improved
our
knowledge
gut
microbiome
in
human
health
and
disease,
including
Alzheimer’s
disease
(AD),
a
neurodegenerative
disorder.
Frequent
bidirectional
communications
mutual
regulation
exist
between
the
gastrointestinal
tract
central
nervous
system
through
gut-brain
axis.
A
large
body
research
reported
close
association
microbiota
AD
development,
restoring
healthy
may
curb
or
even
improve
symptoms
progression.
Thus,
modulation
become
novel
paradigm
for
clinical
management
AD,
emerging
effort
focused
on
developing
potential
strategies
preventing
and/or
treating
disease.
In
this
review,
we
provide
an
overview
connection
causal
relationship
dysbiosis
mechanisms
driving
progression,
successes
challenges
implementing
available
microbiome-targeted
therapies
(including
probiotics,
prebiotics,
synbiotics,
postbiotics,
fecal
transplantation)
preventive
therapeutic
preclinical
intervention
studies
AD.
Finally,
discuss
future
directions
field.
Journal of Neuroinflammation,
Journal Year:
2019,
Volume and Issue:
16(1)
Published: March 1, 2019
Development
of
central
nervous
system
(CNS)
is
regulated
by
both
intrinsic
and
peripheral
signals.
Previous
studies
have
suggested
that
environmental
factors
affect
neurological
activities
under
physiological
pathological
conditions.
Although
there
anatomical
separation,
emerging
evidence
has
indicated
the
existence
bidirectional
interaction
between
gut
microbiota,
i.e.,
(diverse
microorganisms
colonizing
human
intestine),
brain.
The
cross-talk
microbiota
brain
may
crucial
impact
during
basic
neurogenerative
processes,
in
neurodegenerative
disorders
tumors
CNS.
In
this
review,
we
discuss
biological
interplay
gut-brain
axis,
further
explore
how
communication
be
dysregulated
diseases.
Further,
highlight
new
insights
modification
composition,
which
emerge
as
a
promising
therapeutic
approach
to
treat
CNS
disorders.
Clinical Microbiology Reviews,
Journal Year:
2022,
Volume and Issue:
35(1)
Published: Jan. 5, 2022
The
human
body
is
full
of
an
extensive
number
commensal
microbes,
consisting
bacteria,
viruses,
and
fungi,
collectively
termed
the
microbiome.
initial
acquisition
microbiota
occurs
from
both
external
maternal
environments,
vast
majority
them
colonize
gastrointestinal
tract
(GIT).
These
microbial
communities
play
a
central
role
in
maturation
development
immune
system,
nervous
GIT
system
are
also
responsible
for
essential
metabolic
pathways.
Various
factors,
including
host
genetic
predisposition,
environmental
lifestyle,
diet,
antibiotic
or
nonantibiotic
drug
use,
etc.,
affect
composition
gut
microbiota.
Recent
publications
have
highlighted
that
imbalance
microflora,
known
as
dysbiosis,
associated
with
onset
progression
neurological
disorders.
Moreover,
characterization
microbiome-host
cross
talk
pathways
provides
insight
into
novel
therapeutic
strategies.
Novel
preclinical
clinical
research
on
interventions
related
to
microbiome
treating
conditions,
autism
spectrum
disorders,
Parkinson's
disease,
schizophrenia,
multiple
sclerosis,
Alzheimer's
epilepsy,
stroke,
hold
significant
promise.
This
review
aims
present
comprehensive
overview
potential
involvement
pathogenesis
particular
emphasis
microbe-based
therapies
and/or
diagnostic
biomarkers.
discusses
health
benefits
administration
probiotics,
prebiotics,
postbiotics,
synbiotics
fecal
transplantation
FEBS Journal,
Journal Year:
2020,
Volume and Issue:
287(5), P. 833 - 855
Published: Jan. 19, 2020
The
intestinal
milieu
harbours
the
gut
microbiota,
consisting
of
a
complex
community
bacteria,
archaea,
fungi,
viruses
and
protozoans
that
bring
to
host
organism
an
endowment
cells
genes
more
numerous
than
its
own.
In
last
10
years,
mounting
evidence
has
highlighted
prominent
influence
mutualistic
bacterial
communities
on
human
health.
Microbial
colonization
occurs
alongside
with
immune
system
development
plays
role
in
physiology.
microbiota
does
not
undergo
significant
fluctuations
throughout
adult
life.
However,
infections,
antibiotic
treatment,
lifestyle,
surgery
diet
might
profoundly
affect
it.
Gut
dysbiosis,
defined
as
marked
alterations
amount
function
microorganisms,
is
correlated
aetiology
chronic
noncommunicable
diseases,
ranging
from
cardiovascular,
neurologic,
respiratory
metabolic
illnesses
cancer.
this
review,
we
focus
interplay
among
provide
perspective
their
unique
metabolites
pathogenesis
and/or
progression
various
disorders.
We
discuss
interventions
based
microbiome
studies,
faecal
transplantation,
probiotics
prebiotics,
introduce
concept
correcting
dysbiosis
can
ameliorate
disease
symptoms,
thus
offering
new
approach
towards
treatment.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Feb. 16, 2024
Abstract
The
human
gastrointestinal
tract
is
populated
with
a
diverse
microbial
community.
vast
genetic
and
metabolic
potential
of
the
gut
microbiome
underpins
its
ubiquity
in
nearly
every
aspect
biology,
including
health
maintenance,
development,
aging,
disease.
advent
new
sequencing
technologies
culture-independent
methods
has
allowed
researchers
to
move
beyond
correlative
studies
toward
mechanistic
explorations
shed
light
on
microbiome–host
interactions.
Evidence
unveiled
bidirectional
communication
between
central
nervous
system,
referred
as
“microbiota–gut–brain
axis”.
microbiota–gut–brain
axis
represents
an
important
regulator
glial
functions,
making
it
actionable
target
ameliorate
development
progression
neurodegenerative
diseases.
In
this
review,
we
discuss
mechanisms
As
provides
essential
cues
microglia,
astrocytes,
oligodendrocytes,
examine
communications
microbiota
these
cells
during
healthy
states
Subsequently,
diseases
using
metabolite-centric
approach,
while
also
examining
role
microbiota-related
neurotransmitters
hormones.
Next,
targeting
intestinal
barrier,
blood–brain
meninges,
peripheral
immune
system
counteract
dysfunction
neurodegeneration.
Finally,
conclude
by
assessing
pre-clinical
clinical
evidence
probiotics,
prebiotics,
fecal
transplantation
A
thorough
comprehension
will
foster
effective
therapeutic
interventions
for
management
Gut Microbes,
Journal Year:
2022,
Volume and Issue:
14(1)
Published: July 28, 2022
Alterations
in
the
gut
microbiota
composition
have
been
associated
with
a
range
of
neurodevelopmental,
neurodegenerative,
and
neuropsychiatric
disorders.
The
microbes
transform
metabolize
dietary-
host-derived
molecules
generating
diverse
group
metabolites
local
systemic
effects.
bi-directional
communication
between
brain
residing
gut,
so-called
gut–brain
axis,
consists
network
immunological,
neuronal,
endocrine
signaling
pathways.
Although
full
variety
mechanisms
crosstalk
is
yet
to
be
established,
existing
data
demonstrates
that
single
metabolite
or
its
derivatives
are
likely
among
key
inductors
within
axis
communication.
However,
more
research
needed
understand
molecular
underlying
how
alter
functions,
examine
if
different
interventional
approaches
targeting
could
used
prevention
treatment
neurological
disorders,
as
reviewed
herein.Abbreviations:4-EPS
4-ethylphenylsulfate;
5-AVA(B)
5-aminovaleric
acid
(betaine);
Aβ
Amyloid
beta
protein;
AhR
Aryl
hydrocarbon
receptor;
ASD
Autism
spectrum
disorder;
BBB
Blood–brain
barrier;
BDNF
Brain-derived
neurotrophic
factor;
CNS
Central
nervous
system;
GABA
ɣ-aminobutyric
acid;
GF
Germ-free;
MIA
Maternal
immune
activation;
SCFA
Short-chain
fatty
3M-4-TMAB
3-methyl-4-(trimethylammonio)butanoate;
4-TMAP
4-(trimethylammonio)pentanoate;
TMA(O)
Trimethylamine(-N-oxide);
TUDCA
Tauroursodeoxycholic
ZO
Zonula
occludens
proteins
Nutritional Neuroscience,
Journal Year:
2019,
Volume and Issue:
24(10), P. 810 - 834
Published: Nov. 4, 2019
Neurodegenerative
diseases
are
characterized
by
the
progressive
functional
loss
of
neurons
in
brain,
causing
cognitive
impairment
and
motoneuron
disability.
Although
multifactorial
interactions
evident,
nutrition
plays
an
essential
role
pathogenesis
evolution
these
diseases.
A
systematic
literature
search
was
performed,
prevalence
studies
evaluated
effect
Mediterranean
diet
(MeDiet),
nutritional
support,
EPA
DHA,
vitamins
on
memory
cognition
impairment.
The
data
showed
that
malnutrition
low
body
mass
index
(BMI)
is
correlated
with
higher
development
dementia
mortality.
MeDiet,
calorie-controlled
diets
play
a
protective
against
decline,
Alzheimer's
disease
(AD),
Parkinson
(PD)
while
insulin
resistance
represent
significant
risk
factors.
Malnutrition
activates
also
gut-microbiota-brain
axis
dysfunction
exacerbate
neurogenerative
process.
Omega-3
-6,
supplementation
seem
to
be
less
effective
protecting
neuron
degeneration.
Insulin
activity
prevalent
factor
contributing
brain
health
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(3), P. 668 - 668
Published: Feb. 5, 2022
Gut
microbiota
is
emerging
as
a
key
regulator
of
many
disease
conditions
and
its
dysregulation
implicated
in
the
pathogenesis
several
gastrointestinal
extraintestinal
disorders.
More
recently,
gut
microbiome
alterations
have
been
linked
to
neurodegeneration
through
increasingly
defined
brain
axis,
opening
possibility
for
new
microbiota-based
therapeutic
options.
Although
studies
conducted
unravel
possible
relationship
between
Alzheimer’s
Disease
(AD)
progression,
diagnostic
potential
approaches
aiming
at
restoring
eubiosis
remain
be
fully
addressed.
In
this
narrative
review,
we
briefly
summarize
role
homeostasis
health
disease,
present
evidence
AD
patients.
Based
on
these
observations,
then
discuss
how
dysbiosis
might
exploited
tool
early
advanced
stages,
examine
prebiotics,
probiotics,
fecal
transplantation,
diets
complementary
interventions
thus
offering
insights
into
diagnosis
treatment
devastating
progressive
disease.